Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenografts.

Y. van Hensbergen, H.J. Broxterman, S Rana, P.J. van Diest, M.C.A. Duyndam, K. Hoekman, H.M. Pinedo, E. Boven

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1180-91
JournalClinical Cancer Research
Volume10
Issue number3
DOIs
Publication statusPublished - 2004

Cite this